World Bulletin / News Desk
Open access worldwide to the new database, based on genome studies, is expected to help researchers accelerate development of new drugs and better match patients with therapies, NCI said in a statement on Monday.
"Most anti-cancer drugs that are used today are used based on their empirical activity," Dr. Yves Pommier, chief of the NCI's Laboratory of Molecular Pharmacology, said in an interview. "For most of them, we know there is a target, but they have not been connected with any genomics."
Most cancer treatments involve a lot of guess work because doctors have no way to determine how a particular patient is likely to respond to many commonly used drugs or chemotherapy, or which cancers will develop resistance.
To create the database, the NCI team sequenced 60 human cancer cell lines, generating an extensive list of cancer-specific variations for different parts of the body.
"Only about half of women with ovarian cancer respond to it," he said, noting that pharmaceutical companies would have little incentive to determine if an existing cancer drug should only be used in a subset of patients.
Many recently approved cancer drugs are targeted treatments, designed to block specific pathways that cancer cells use to grow and reproduce. Before the drugs are administered, patients are tested for the specific genetic mutations that would make the drug more likely to be beneficial to them.
Melanoma drug Zelboraf, sold by Roche Holding AG, is designed to work by targeting a specific genetic mutation found in about half of all melanomas. Pfizer Inc's cancer drug Xalkori, which targets a mutation in the ALK gene, works in about 4 percent of lung cancer patients.
A blind Muslim Microsoft engineer has unveiled an AI-powered project that helps him 'see' the world
Google is being accused of using practices aimed at preserve its market dominance
Quantum spin liquid validates theory first suggested in 1973
International Civil Aviation Organization 'recognizes that sub-orbital and outer space flights will foster new tourism and transport market'
A joint European-Russian mission aiming to search for traces of life on Mars blasted off on Monday for the start of a seven-month unmanned space journey to the Red Planet.
Scott Kelly has spent more time in space than any other American and has returned back from his mission
Administrator touts success in planetary study, deep-space experiments, aviation innovation
A man left brain-dead after an experimental drug trial in France has died, local media report.
Facebook founder to donate majority of fortune over lifetime to newly formed charity
Facebook will appeal a date privacy ruling in Belgium that forces the social media giant to stop collecting digital information about people who are non-members
Japanese, Chinese, Irish scientists win 2015 Nobel prize in medicine for malaria and parasite research
Discovery could have major implications for pursuit of life on the red planet
Lawsuit sheds light on no poaching policy at Silicon Valley’s biggest companies
Searches for oncoming storms will display information such as maps, forecasts, reminders and preparedness instructions
New service unveiled as survey finds Americans having hard time navigating smartphone etiquette